Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT04968860
Eligibility Criteria:
Inclusion Criteria:
* Patients who, based on the agreement of parents and/or guardians, agree to participate in the research with a signed "Informed Consent Form"
* Patients from 3 to 17 years of age
* Patients older than 6 years must not only have parental and/or guardian authorization must have the consent term
* Patients who have not started antineoplastic treatment
* Patients with ALL only with BFM protocol
* AML patients with BFM protocol only
Exclusion Criteria:
* Responsible for patients who do not sign the free and informed consent form.
* Patients under three years of age and over 17 years of age
* Children older than six years who do not agree to the term of assent
* Patients who have started antineoplastic treatment
* Patients with syndromes and/or other systemic diseases associated with the diagnosis of lymphoid and acute myeloid leukemia
* Neoplasms other than lymphoid leukemia or acute myeloid
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
17 Years
Study:
NCT04968860
Study Brief:
Protocol Section:
NCT04968860